Cargando…

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study

OBJECTIVE: To examine the association between optimal adherence to the first-generation injectable immunomodulatory drugs (IMDs) for multiple sclerosis (MS) and subsequent disability accumulation. METHODS: We accessed prospectively collected linked clinical and administrative health data from Britis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingting, Kingwell, Elaine, Zhu, Feng, Petkau, John, Kastrukoff, Lorne F, Marrie, Ruth Ann, Tremlett, Helen, Evans, Charity
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640095/ https://www.ncbi.nlm.nih.gov/pubmed/28965103 http://dx.doi.org/10.1136/bmjopen-2017-018612

Ejemplares similares

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
por: McKay, Kyla, et al.
Publicado: (2017)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study
por: Evans, Charity, et al.
Publicado: (2021)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

A population‐based study comparing multiple sclerosis clinic users and non‐users in British Columbia, Canada
por: McKay, K. A., et al.
Publicado: (2016)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
por: Shirani, Afsaneh, et al.
Publicado: (2015)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study
por: Al-Sakran, Lina, et al.
Publicado: (2019)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
por: McKay, Kyla A, et al.
Publicado: (2016)

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
por: Zhang, Tingting, et al.
Publicado: (2016)

Evaluating the safety of β-interferons in MS: A series of nested case-control studies
por: de Jong, Hilda J.I., et al.
Publicado: (2017)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

The Multiple Sclerosis Prodrome: Evidence to Action
por: Tremlett, Helen, et al.
Publicado: (2022)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

Beta‐interferon exposure and onset of secondary progressive multiple sclerosis
por: Zhang, T., et al.
Publicado: (2015)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022)

Incidence and prevalence of multiple sclerosis in Europe: a systematic review
por: Kingwell, Elaine, et al.
Publicado: (2013)

Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis
por: Xue, Huiru, et al.
Publicado: (2021)

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
por: Kingwell, Elaine, et al.
Publicado: (2015)

Women's Health in Multiple Sclerosis: A Scoping Review
por: Ross, Lindsay, et al.
Publicado: (2022)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

Models of Care in Multiple Sclerosis: A Survey of Canadian Health Providers
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Alzheimer’s disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT)
por: Boukhvalova, Marina S., et al.
Publicado: (2023)

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
por: Palace, Jacqueline, et al.
Publicado: (2014)

Variants of Novel Immunomodulatory Fc Receptor Like 5 Gene Are Associated With Multiple Sclerosis Susceptibility in the Polish Population
por: Chorazy, Monika, et al.
Publicado: (2021)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis
por: Tóth, Eszter, et al.
Publicado: (2019)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS
por: Petrin, Julie, et al.
Publicado: (2023)

Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia
por: Alsaedi, Esraa Q, et al.
Publicado: (2022)

How is neuromuscular fatigability affected by perceived fatigue and disability in people with multiple sclerosis?
por: Royer, Nicolas, et al.
Publicado: (2022)

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2jsnfe0rlbt1kk11jamfj57j27